BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company, today announced that it has been added to the NASDAQ Biotechnology Index® (NASDAQ:NBI). Re-rankings of the Index are semi-annual and are effective with the market open on Monday, May 21, 2007.
